Phase 3 HIV Infection Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 3
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
HIV Infections
ViiV Healthcare3,508 enrolled34 locationsNCT06134362
Recruiting
Phase 3
Antiretroviral Therapy for Acute and Chronic HIV Infection
Acute HIV InfectionChronic HIV Infection
SEARCH Research Foundation900 enrolled1 locationNCT00796263
Recruiting
Phase 3
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
HIV InfectionsSubstance UseAdherence, Treatment+1 more
Brigham and Women's Hospital40 enrolled1 locationNCT05378399
Recruiting
Phase 3
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
HIV InfectionsAdherence, Medication
University of Illinois at Chicago126 enrolled1 locationNCT06550804
Recruiting
Phase 3
The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
HIV Infections
Evandro Chagas National Institute of Infectious Disease1,200 enrolled1 locationNCT05515770
Recruiting
Phase 3
Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT
HIV Infections
Africa Health Research Institute2,000 enrolled1 locationNCT06250504